My Portfolio

Pfizer Inc PFE:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 2:10 PM EDT

25.45

-0.11 (-0.41%)

Volume

11,342,698

52 week range

23.06 - 28.75

Open25.43
Day High25.62
Day Low25.29
Prev Close25.55
52 Week High28.75
52 Week High Date04/02/26
52 Week Low23.06
52 Week Low Date06/03/25

Latest On Pfizer Inc

Pfizer CEO Albert Bourla on the company's obesity drug pipelineJune 2, 2026CNBC.com
Pfizer CEO Albert Bourla on the company's oncology focusJune 2, 2026CNBC.com
Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trialMay 31, 2026CNBC.com
Portal Innovations' Flavin on M&A activity in the pharma spaceMay 29, 2026CNBC.com
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billionMay 28, 2026CNBC.com
BMO's Evan Seigerman on GLP-1 developments, state of weight-loss drug battleMay 27, 2026CNBC.com
Dr. Scott Gottlieb on Ebola outbreak: This is an outbreak that's out of control in West AfricaMay 26, 2026CNBC.com
28. IslandMay 19, 2026CNBC.com
Bristol Myers Squibb turns to China to develop new drugsMay 15, 2026CNBC.com
FDA head resigning boosts healthcare stocks short-term, but still a lot of unknowns: Mizuho's HolzMay 12, 2026CNBC.com

Key Stats

Market Cap145.022B
Shares Out5.70B
10 Day Average Volume32.80M
Dividend1.72
Dividend Yield6.76%
Beta0.30

Latest On Pfizer Inc

Pfizer CEO Albert Bourla on the company's obesity drug pipelineJune 2, 2026CNBC.com
Pfizer CEO Albert Bourla on the company's oncology focusJune 2, 2026CNBC.com
Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trialMay 31, 2026CNBC.com
Portal Innovations' Flavin on M&A activity in the pharma spaceMay 29, 2026CNBC.com
Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billionMay 28, 2026CNBC.com
BMO's Evan Seigerman on GLP-1 developments, state of weight-loss drug battleMay 27, 2026CNBC.com
Dr. Scott Gottlieb on Ebola outbreak: This is an outbreak that's out of control in West AfricaMay 26, 2026CNBC.com
28. IslandMay 19, 2026CNBC.com
Bristol Myers Squibb turns to China to develop new drugsMay 15, 2026CNBC.com
FDA head resigning boosts healthcare stocks short-term, but still a lot of unknowns: Mizuho's HolzMay 12, 2026CNBC.com

KEY STATS

Open25.43
Day High25.62
Day Low25.29
Prev Close25.55
52 Week High28.75
52 Week High Date04/02/26
52 Week Low23.06
52 Week Low Date06/03/25
Market Cap145.022B
Shares Out5.70B
10 Day Average Volume32.80M
Dividend1.72
Dividend Yield6.76%
Beta0.30

RATIOS/PROFITABILITY

EPS (TTM)1.31
P/E (TTM)19.46
Fwd P/E (NTM)8.99
EBITDA (TTM)26.38B
ROE (TTM)8.29%
Revenue (TTM)63.314B
Gross Margin (TTM)74.80%
Net Margin (TTM)11.88%
Debt To Equity (MRQ)71.54%

EVENTS

Earnings Date08/03/2026(est)
Ex Div Date05/08/2026
Div Amount0.43
Split Date-
Split Factor-

Content From Our Affiliates

Pfizer’s Bevacizumab Biosimilar Safety Study in Japan Reaches Completion: What Investors Should Watch2 Hours AgoTipRanks
Pfizer’s ODEN Study Update: Real-World Data on Tofacitinib in Ulcerative Colitis2 Hours AgoTipRanks
FDA issues draft guidance to help accelerated cell, gene therapies for patientsJune 2, 2026TipRanks
Bernstein Keeps Their Hold Rating on Pfizer (PFE)June 2, 2026TipRanks
Moderately bullish activity in Pfizer with shares down 2.08%June 1, 2026TipRanks

Profile

Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta...

Albert Bourla Ph.D.

Chairman of the Board, Chief Executive Officer

David Denton

Executive Vice President, Chief Financial Officer

Alexandre de Germay

Executive Vice President, Chief International Commercial Officer

Aamir Malik

Executive Vice President, Chief U.S. Commercial Officer

Lidia Fonseca

Executive Vice President, Chief Digital and Technology Officer

Address

66 HUDSON BOULEVARD EAST

New York, NY

10001-2192

United States

https://www.pfizer.com/